Results 191 to 200 of about 19,651 (218)

Therapeutic Response to Myosin Inhibitor Therapy in Noonan Syndrome-Associated Obstructive Hypertrophic Cardiomyopathy. [PDF]

open access: yesJACC Case Rep
Feidakis A   +7 more
europepmc   +1 more source

Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy. [PDF]

open access: yesJ Am Heart Assoc
Ibrahim R   +9 more
europepmc   +1 more source

Target population for a selective cardiac myosin inhibitor in hypertrophic obstructive cardiomyopathy: Real-life estimation from the French register of hypertrophic cardiomyopathy (REMY)

open access: green
Alessandro Parodi   +10 more
openalex   +2 more sources

Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy During Active Chemotherapy. [PDF]

open access: yesJACC Case Rep
Caro-Codón J   +9 more
europepmc   +1 more source

A song of heads and tails: myosin II conformational regulation and filament dynamics shape force generation in non-muscle cells. [PDF]

open access: yesBiophys Rev
Pérez-Díaz R   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy